The percentage of cell proliferation and BrdU-positive cells were significantly reduced in the group of TSC-EVs with anti-NGF compared with only TSC-EV-treated MSCs (Fig. 7F, G, H, I). The gene discussed is NGF; the disease is tuberous sclerosis.